NDA With a Cosmetic Manufacturer: What Buyers Should Check

What an NDA actually protects, and what it does not

Start by being honest about the scope of the document, because most disappointment comes from expecting it to do another agreement's job.

An NDA protects **information**. It says: here is defined confidential material, here is who may see it, here is what they may use it for, and here is how long the duty lasts.

It is well suited to:

• Your brand plans, launch timing and target markets
• Your sales data, costings and target pricing
• Artwork, naming and positioning before launch
• Formulas and specifications you bring to the factory
• The fact of the discussion itself, if you need that kept quiet

It does **not** do the following, even though buyers often assume it does:

• **It does not decide who owns a formula developed during the project.** Ownership is a separate question, settled in a development or manufacturing agreement.
• **It does not stop a factory serving your competitors.** That requires an exclusivity clause, which is a commercial negotiation with a price attached.
• **It does not protect an idea.** A product concept such as a rice-extract serum is not confidential information; the specific formula, supplier list and costings are.
• **It does not protect information already public, independently developed, or lawfully obtained elsewhere.** Standard carve-outs exist in every reasonable NDA and should.
• **It does not substitute for supplier verification.** A signature tells you nothing about whether the company is solvent, competent or even properly registered.

The practical conclusion: sign a sensible NDA early so you can speak freely, and plan from the start for the development and manufacturing agreement that follows. Treating the NDA as the whole of your legal protection is the most common and most expensive misunderstanding in this process.

The clauses worth reading twice

Most templates are broadly similar. The differences that matter cluster in a few places.

**Definition of confidential information.** Too narrow and your most valuable material falls outside it. Too broad and the agreement becomes unenforceable in practice. A workable approach covers information disclosed in any form, written or oral, with oral disclosures confirmed in writing within a short period if the agreement requires it.

**Permitted purpose.** This is the clause buyers skip and should not. State that the information may be used only to evaluate and perform this specific project. Without it, a factory could argue it was free to use your costings for general business purposes.

**Permitted recipients.** The factory needs to share your brief internally and sometimes with raw material suppliers or testing labs. Allow that, but require those third parties to be bound by equivalent terms and make the factory responsible for their breaches.

**Duration.** Two periods matter: the term during which disclosures are covered, and the survival period during which the duty of confidence continues. A short survival period on formula and costing data is weak protection; think in years, not months.

**Return or destruction of materials** at the end of the discussion, with written confirmation on request.

**No licence and no obligation.** Make it explicit that disclosing information grants no rights to use it commercially and creates no obligation to place an order.

**Remedies.** A right to injunctive relief matters, because damages for leaked commercial information are notoriously hard to quantify.

**Governing law and dispute forum.** See the section below — this determines whether the document is practically useful or merely decorative.

Mutual or one-way, and why factories push back

Buyers usually arrive with a one-way NDA protecting only themselves. Established factories usually propose a mutual one. Both positions are reasonable, and understanding why saves an unnecessary argument.

A competent manufacturer has genuine confidential information too: its base formulations, its process know-how, its raw material sources, its pricing structure and often its other clients' existence. If you ask it to disclose formulation detail during development, it will want that protected. A reputable skincare manufacturer in Thailand that handles brands you would recognise has a real obligation to those clients, and a mutual agreement is how it keeps faith with everyone.

What to accept readily:

• Mutual obligations, where both sides are protected on the same terms
• Reasonable carve-outs for public, pre-existing and independently developed information
• Disclosure to professional advisers and to regulators where required by law

What to question:

• **Asymmetric durations** — their obligations lasting one year while yours last five
• **A clause granting them a licence to use your materials** for marketing, portfolio or sample display without your consent
• **A non-solicitation clause drafted so broadly** that it limits your ability to work with other suppliers
• **A clause that converts the NDA into an exclusivity commitment on your side**, requiring you to source only from them

One signal worth noting. A factory that refuses any confidentiality agreement at all is unusual and worth asking about directly. A factory that insists on its own mutual template is normal; ask for it, read it, and negotiate the specific clauses above rather than rejecting the document.

The agreements an NDA does not replace

The NDA opens the conversation. These are the documents that determine what happens when things go well, and when they go wrong.

**A development agreement**, covering who pays for formulation work, how many sample rounds are included, what happens if the brief changes, and critically who owns the resulting formula. The three common outcomes are: factory owns it and you have a licence while you keep ordering; you own it and can take it elsewhere; or joint ownership with defined rights. Each is defensible. What is not defensible is leaving it unwritten and discovering the answer during a dispute.

**A manufacturing or supply agreement**, covering specifications, quality standards, batch documentation, inspection and acceptance rights, what counts as a defect, remedies for out-of-specification batches, change control for formula and supplier changes, lead time expectations, and liability.

**Tooling and artwork ownership**, if custom moulds or printing plates are made. Who paid, who owns, who stores, and what happens if you move production.

**Exclusivity, if you want it**, scoped properly: exclusive to what — the exact formula, the category, a territory, a channel? And for how long, in exchange for what commitment? Broad exclusivity requests from a brand with no track record are usually declined, and that is a normal commercial response rather than a bad sign.

**Trademark protection**, which is a separate system entirely. An NDA does nothing for your brand name. Register the mark in the markets that matter to you, and do it before public launch.

The sequence that works: NDA, then brief and samples, then development agreement before meaningful formulation spend, then manufacturing agreement before the first production order.

Signing, jurisdiction and what enforcement really looks like

A confidentiality agreement is only as useful as your ability to act on it, which depends on unglamorous details.

**Sign with the right entity.** Verify the registered company name and number, confirm the signatory has authority, and make sure the entity on the NDA is the same one that will later invoice you. An NDA signed with a sales agency affiliated with the factory may not bind the factory.

**Governing law and forum.** A clause choosing a distant jurisdiction may look protective and be impractical. Enforcing against a Thai company is generally most realistic where its assets are. Discuss with your lawyer whether Thai law and Thai courts, or a named arbitration seat, is the better practical choice for your situation. Arbitration clauses can be effective but carry their own costs, so they suit larger commitments more than first projects.

**Language.** If the agreement exists in two languages, state which version prevails. Do not leave this to chance.

**Keep records.** Mark documents as confidential, keep a dated log of what you disclosed and when, and send material through channels you can evidence. If you ever need to rely on the agreement, this log is the difference between a claim and an assertion.

**Be realistic.** Cross-border enforcement is slow and expensive, and the practical value of an NDA is mostly deterrent and clarifying. That is a reason to stage your disclosures, not a reason to skip the document. Share what each stage of the conversation genuinely requires: category and brief first, detailed formulation and costings only once you have run proper supplier verification and are seriously engaged.

A buyer checklist, and the red flags

Before you sign, work through this list with your adviser.

1. **Correct parties** — registered entity names and numbers verified, signatory authority confirmed. 2. **Mutual obligations** on equivalent terms and equivalent durations. 3. **Confidential information defined** to cover written and oral disclosure in any medium. 4. **Permitted purpose limited** to this specific project. 5. **Permitted recipients defined**, with the factory responsible for its own people and subcontractors. 6. **Survival period measured in years** for formula, costing and supplier data. 7. **No implied licence**, and no obligation to order. 8. **Return or destruction** of materials on request. 9. **Injunctive relief** available. 10. **Governing law and forum** that you could realistically use. 11. **Prevailing language** specified. 12. **Reviewed by your own lawyer**, not only by the counterparty's.

Red flags in the document or the conversation:

• Terms that bind you far more tightly than them
• A clause letting them display your product or brand in their portfolio without consent
• Any attempt to establish formula ownership inside the NDA rather than in a development agreement
• An entity name that does not match the company you have been verifying
• Pressure to sign immediately, or to skip the agreement because everyone here is trustworthy
• Reluctance to discuss what happens to your formula if you stop ordering

A sensible next step: ask each shortlisted factory for its standard NDA and development agreement at the same time. How a company handles that request tells you more about working with it than any factory tour. For a perfume manufacturer this matters even more than for skincare, because fragrance houses and factories often treat scent formulations as permanently proprietary, so clarify ownership of a bespoke scent before paying for development. And if you prefer one partner coordinating formulation, packaging and documentation under a single agreement rather than negotiating with several suppliers in parallel, a managed OEM and ODM model such as 5FINE (5fineglobal.com) is one structure to compare — reviewed by your own lawyer, as with any other.